Drugs: Krebiozen & Cancer

''The stage is now set for ultimate resolution of this thing," said Director Kenneth Endicott of the National Cancer Institute last week, with a vast sigh of relief. Under last year's tightened drug-control laws, the Food and Drug Administration is at last launching an all-out investigation to answer a question that has caused savage controversy for twelve years: Is there any basis for the claims that Krebiozen, a mysterious horse-serum drug, is a cure for some forms of cancer? Though Krebiozen has never been approved by any federal agency, about 3,500 doctors...

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on TIME.com

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!